Global Skin Grafting System Market Size study & Forecast, by Product, Type, Wound Type & End User and Regional Analysis, 2022-2029

  • Publish Date: Jan,2023
  • Report ID: 3-2-1240
  • Page : 200
  • Report Type : PDF (Email)
Global Skin Grafting System Market is valued approximately at USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period 2022-2029. Skin Grafting System is a technique used to conduct a surgical procedure to cover skin replacement across various wound implications like skin cancer, deep burns, injury etc. The Skin Grafting System market is expanding because of factors such as rising cases of skin disorders and availability of advanced healthcare infrastructure in the forecast period.

According to American Academy of Dermatology Association in 2020, around 50 million Americans are affected by acne and other skin problems. Approximately 85% people between aged 12 to 24 are experiencing at acne and other skin disorders . It includes bullous disease, benign neoplasms, keloids, scars, cysts, actinic damage etc. Rising spending on personal healthcare and growing R&D activities by market players creates lucrative opportunities for the market. However, costly procedure of skin grafting hampers the market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Skin Grafting System Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America dominates the market with highest revenue, owing to the increasing cases of skin disorders, majority of burn cases and growing spending towards personal healthcare. Whereas, Asia Pacific is anticipated to grow with the fastest growth rate owing to the rising penetration of market players, rising spendings towards skincare etc.

Major market players included in this report are:

Zimmer Inc.,

Aesculap, Inc.

AB. Braun company

Nouvag AG

De Soutter Medical Limited

Surtex Instruments Limited.

Exsurco Medical, Inc.

Ygun co., inc,

Mdc(thailand) co., ltd.,

A.D. Surgical

Recent Developments in the Market:

In September 2019 -Mallinckrodt has declared positive results from a phas-3 trial of Strata graft. The company is planning to apply for U.S FDA approval based on the results to commercialize the treatment procedure and product.
Global Skin Grafting System Market Report Scope:

Historical Data: 2019-2020-2021

Base Year for Estimation: 2021

Forecast period: 2022-2029

Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends

Segments Covered: Product, Type, Wound, End-User, Region

Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World

Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:

Dermatome Devices

Wound Debridement Devices

By Type:



By Wound:


Surgical Wounds,



Pressure Ulcers

By End-User:


By Region:

North America










Asia Pacific





South Korea


Latin America



Rest of the World